Instructional Video7:32
Curated Video

Rethinking ADHD Treatment: The Power of Non-Stimulant Medication

Higher Ed
Explore ADHD treatment beyond stimulants with Dr. Tracey Marks. Dive into the world of non-stimulant medications like Qelbree, and their potential to improve executive function and work productivity in adults with ADHD. Uncover the...
Instructional Video6:38
Curated Video

7 Warning Signs You Need a Mental Wellness Check

Higher Ed
How good are you at recognizing early signs that your mental health is slipping? It’s very hard to pull yourself out of a hole when you bottom out from depression. It’s much easier to change your course if you haven’t gotten too low....
Instructional Video27:23
The Wall Street Journal

J Balvin's Vision for the Music Industry

Higher Ed
J Balvin is one of the best-selling Latin music artists of all time and joins us for a conversation about the future of the music industry and why he’s using his platform to change the conversation around mental health.
Instructional Video11:31
The Wall Street Journal

The Cyber Risk Executive Briefing

Higher Ed
WSJ Pro's Cyber Risk Analyst Marilia Wyatt shares insights from a study measuring cybersecurity preparedness across the business community.
Stock Footage0:10
Getty Images

Lost Identity

Pre-K - Higher Ed
Lost Identity
News Clip23:08
Curated Video

Next Level: Do Video Games Help Or Hurt Our Mental Health?

Higher Ed
In each episode of Next Level, Newsy explores the real-world impacts of the largest entertainment industry on Earth: video games.
News Clip2:37
Curated Video

Could Artificial Intelligence Help Patients With Schizophrenia?

Higher Ed
An app that uses artificial intelligence to measure thinking and speech patterns could help patients with schizophrenia.
News Clip7:49
Bloomberg

NFL Star Richard Sherman Invests in HealthTech Company

Higher Ed
Jun.09 -- Nurosene is a health-tech company aiming to improve daily mental wellness and overall brain health. The company started trading today on the Canadian Stock Exchange under the ticker 'MEND'. It's getting some big backing from...